
in transfers of value from the pharmaceutical industry to healthcare professionals and organisations were disclosed for 2025, up 14.3% on 2024.
ABPI, Disclosure UK 2025: the 11th year of Disclosure UK data, June 2026
of Disclosure UK data are now published, recording payments and benefits from the pharmaceutical industry to healthcare professionals and organisations.
ABPI, Disclosure UK 2025: the 11th year of Disclosure UK data, June 2026.
Every advisory board should end with a decision you can make or a plan you can change.
We plan each one around that, so the question, the experts and the agenda all point to it.
That applies whether it is key opinion leader engagement, an advisory board to shape a study, or an internal cross-functional workshop.
We then write up the insight with recommendations, alongside the records your compliance team needs for fee review and Disclosure UK reporting.

Take Real-World Research Further
If you would like to discuss a programme, please get in touch.